Nature Communications (May 2024)

Liver ACOX1 regulates levels of circulating lipids that promote metabolic health through adipose remodeling

  • Dongliang Lu,
  • Anyuan He,
  • Min Tan,
  • Marguerite Mrad,
  • Amal El Daibani,
  • Donghua Hu,
  • Xuejing Liu,
  • Brian Kleiboeker,
  • Tao Che,
  • Fong-Fu Hsu,
  • Monika Bambouskova,
  • Clay F. Semenkovich,
  • Irfan J. Lodhi

DOI
https://doi.org/10.1038/s41467-024-48471-2
Journal volume & issue
Vol. 15, no. 1
pp. 1 – 16

Abstract

Read online

Abstract The liver gene expression of the peroxisomal β-oxidation enzyme acyl-coenzyme A oxidase 1 (ACOX1), which catabolizes very long chain fatty acids (VLCFA), increases in the context of obesity, but how this pathway impacts systemic energy metabolism remains unknown. Here, we show that hepatic ACOX1-mediated β-oxidation regulates inter-organ communication involved in metabolic homeostasis. Liver-specific knockout of Acox1 (Acox1-LKO) protects mice from diet-induced obesity, adipose tissue inflammation, and systemic insulin resistance. Serum from Acox1-LKO mice promotes browning in cultured white adipocytes. Global serum lipidomics show increased circulating levels of several species of ω−3 VLCFAs (C24-C28) with previously uncharacterized physiological role that promote browning, mitochondrial biogenesis and Glut4 translocation through activation of the lipid sensor GPR120 in adipocytes. This work identifies hepatic peroxisomal β-oxidation as an important regulator of metabolic homeostasis and suggests that manipulation of ACOX1 or its substrates may treat obesity-associated metabolic disorders.